Holen Sie sich die Stockscreener-App
0.86
26.38%
0.1795
Handel nachbörslich:
.80
-0.06
-6.98%
Schlusskurs vom Vortag:
$0.6805
Offen:
$0.6964
24-Stunden-Volumen:
19.24M
Relative Volume:
23.93
Marktkapitalisierung:
$11.78M
Einnahmen:
$1.89M
Nettoeinkommen (Verlust:
$-17.92M
KGV:
-0.1286
EPS:
-6.69
Netto-Cashflow:
$-15.62M
1W Leistung:
-42.47%
1M Leistung:
-39.44%
6M Leistung:
-45.22%
1J Leistung:
-67.67%
1-Tages-Spanne:
$0.69
$0.94
1-Wochen-Bereich:
$0.633
$1.52
52-Wochen-Spanne:
$0.633
$2.86
Longeveron Inc Stock (LGVN) Company Profile
Firmenname
Longeveron Inc
Sektor
Branche
Telefon
305-302-7158
Adresse
1951 NW 7TH AVENUE, MIAMI
Vergleichen Sie LGVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.86 | 10.33M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
Longeveron Inc Aktie (LGVN) Neueste Nachrichten
Longeveron Posts 32% Revenue Drop in Q2 - Nasdaq
Longeveron's Stem Cell Therapy for Fatal Child Heart Condition Reaches Critical Trial Phase - Stock Titan
Longeveron Inc (LGVN) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Detecting price anomalies in Longeveron Inc. with AIJuly 2025 Outlook & Short-Term High Return Ideas - Newser
Does Longeveron Inc. outperform in volatile marketsJuly 2025 Momentum & Low Volatility Stock Recommendations - thegnnews.com
Why Longeveron Inc. stock attracts strong analyst attentionTrade Entry Summary & Free Daily Entry Point Trade Alerts - Newser
What does recent volatility data suggest for Longeveron Inc. [Weekly Trade Report]Free Pattern Based Trade Signal System - Newser
Regression analysis insights on Longeveron Inc. performanceQuarterly Profit Review & Target Return Focused Stock Picks - Newser
Will breakout in Longeveron Inc. lead to full recoveryLong Term Equity Screener with Safety Metrics - Newser
What makes Longeveron Inc. stock price move sharplyIntraday Price Forecast Using Volume Models - Newser
Longeveron Announces Up To $17.5 Million Public Offering - MarketScreener
Longeveron Inc (LGVN) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Longeveron (LGVN) to Release Quarterly Earnings on Wednesday - Defense World
What’s the recovery path for long term holders of Longeveron Inc.Pattern Breakout Prediction for Short Term - Newser
What MACD and RSI say about Longeveron Inc.Historical Stock Summary and ROI Review - Newser
Backtesting results for Longeveron Inc. trading strategiesFree Low Volatility Stable Growth Picks - Newser
Using economic indicators to assess Longeveron Inc. potentialChart Pattern Recognition for Profit Timing - Newser
Longeveron closes $5 million public offering of common stock By Investing.com - Investing.com Nigeria
Longeveron closes $5 million public offering of common stock - Investing.com
Longeveron Announces Closing Of Up To $17.5 Million Public Offering - The Manila Times
Longeveron Secures $17.5M Funding: Insiders Back Regenerative Medicine Breakthrough Development - Stock Titan
Technical signs of recovery in Longeveron Inc.Free Technical Entry Strategy for Beginners - Newser
Longeveron LGVN Q2 2025 Earnings Preview Upside Potential on Stem Cell Therapy Advancements - AInvest
Longeveron Inc. recovery potential after sell offReal-Time Investment Signal Forecast with AI - Newser
Chart based analysis of Longeveron Inc. trendsEntry Opportunity Screener with Confirmation - Newser
Longeveron's Capital Raise and Dilution Crisis: A Cautionary Tale for Biotech Investors - AInvest
Will Longeveron Inc. outperform tech stocksFree Portfolio Health Check - classian.co.kr
Published on: 2025-08-09 06:48:26 - Newser
Longeveron launches offering of up to 11.8M shares via warrants and stock units - MSN
New Product Launches: Will They Boost Longeveron Inc. Stock in 2025Watchlist Generator for Smart Money Signals - Newser
Short Interest in Longeveron Inc. (NASDAQ:LGVN) Grows By 58.4% - Defense World
Will Longeveron Inc. stock go up soonFree Daily Momentum Screener With Alerts - Newser
Longeveron Plummets 46%: A $17.5M Raise Sparks Investor Panic—What’s Next for the Biotech? - AInvest
Real time pattern detection on Longeveron Inc. stockWeekly Signal Report with Trend Summary - Newser
Longeveron Shares Fall After Company Prices Public Offering - MarketScreener
Longeveron Prices Offering Of 5.88M Shares And 14.7M Accompanying Short-Term Warrants At $0.85; Expected To Be - 富途牛牛
Longeveron Secures $17.5M Financing: Major Push for HLHS and Alzheimer's Drug Development - Stock Titan
Why Nebius Group Stock Was Soaring Today - The Globe and Mail
Longeveron Inc. stock trend outlook and recovery pathSmart Chart Forecasting with AI Algorithms - Newser
Buy Signal for Longeveron Inc. Stock Key Technical Indicators to WatchHigh Confidence Strategy with Trend Alignment - Newser
Press Release: Longeveron(R) to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13, 2025 - 富途牛牛
Longeveron® to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13, 2025 - The Manila Times
Finanzdaten der Longeveron Inc-Aktie (LGVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):